1. Home
  2. SKY vs LSBPW Comparison

SKY vs LSBPW Comparison

Compare SKY & LSBPW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SKY
  • LSBPW
  • Stock Information
  • Founded
  • SKY 2010
  • LSBPW N/A
  • Country
  • SKY United States
  • LSBPW China
  • Employees
  • SKY N/A
  • LSBPW 758
  • Industry
  • SKY Homebuilding
  • LSBPW Biotechnology: Pharmaceutical Preparations
  • Sector
  • SKY Consumer Discretionary
  • LSBPW Health Care
  • Exchange
  • SKY Nasdaq
  • LSBPW Nasdaq
  • Market Cap
  • SKY N/A
  • LSBPW N/A
  • IPO Year
  • SKY N/A
  • LSBPW N/A
  • Fundamental
  • Price
  • SKY $90.61
  • LSBPW $0.06
  • Analyst Decision
  • SKY Hold
  • LSBPW
  • Analyst Count
  • SKY 5
  • LSBPW 0
  • Target Price
  • SKY $85.40
  • LSBPW N/A
  • AVG Volume (30 Days)
  • SKY 1.3M
  • LSBPW N/A
  • Earning Date
  • SKY 02-04-2025
  • LSBPW N/A
  • Dividend Yield
  • SKY N/A
  • LSBPW N/A
  • EPS Growth
  • SKY N/A
  • LSBPW N/A
  • EPS
  • SKY 2.58
  • LSBPW N/A
  • Revenue
  • SKY $2,340,474,000.00
  • LSBPW N/A
  • Revenue This Year
  • SKY $20.55
  • LSBPW N/A
  • Revenue Next Year
  • SKY $7.01
  • LSBPW N/A
  • P/E Ratio
  • SKY $35.07
  • LSBPW N/A
  • Revenue Growth
  • SKY 16.86
  • LSBPW N/A
  • 52 Week Low
  • SKY $64.82
  • LSBPW N/A
  • 52 Week High
  • SKY $116.49
  • LSBPW N/A
  • Technical
  • Relative Strength Index (RSI)
  • SKY 45.85
  • LSBPW N/A
  • Support Level
  • SKY $85.25
  • LSBPW N/A
  • Resistance Level
  • SKY $95.26
  • LSBPW N/A
  • Average True Range (ATR)
  • SKY 3.03
  • LSBPW 0.00
  • MACD
  • SKY 0.62
  • LSBPW 0.00
  • Stochastic Oscillator
  • SKY 58.81
  • LSBPW 0.00

About LSBPW LakeShore Biopharma Co. Ltd

LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.

Share on Social Networks: